PXI Auto Components
301560
Shenzhen Crastal Technology
300824
Shenzhen Zesum Technology
301486
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
CN Stock MarketDetailed Quotes
300759 Pharmaron Beijing
- 23.19
- +0.11+0.48%
Market Closed Apr 25 15:00 CST
41.24BMarket Cap22.98P/E (TTM)
23.57High22.91Low204.42KlotVolume23.40Open23.08Pre Close475.07MTurnover1.44%Turnover Ratio22.98P/E (Static)1.78BShares36.4252wk High3.03P/B32.92BFloat Cap17.7052wk Low27.70Limit Up1.42BShs Float108.11Historical High18.46Limit Down2.86%Amplitude3.24Historical Low0.20Dividend TTM23.24Avg Price96.59KlotAsk0.86%Div YieldTTM100Lot Size94.05KlotBid
Pharmaron Beijing Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | -71.45%1.69B | -2.80%2B | -4.45%2.4B | 125.41%4.63B | 295.26%5.92B | 0.79%2.06B | -11.79%2.51B | -29.45%2.06B | -57.74%1.5B | -52.39%2.04B |
| Transactional financial assets | 87.65%1.12B | -35.42%596.88M | -43.33%361.09M | 17.04%574.79M | -20.26%594.33M | 32.37%924.25M | 6.62%637.2M | -65.69%491.1M | -52.06%745.36M | -57.99%698.21M |
| Notes receivable and accounts receivable | 7.65%2.41B | 2.27%2.27B | 1.92%2.18B | 1.00%2.09B | 19.14%2.24B | 23.35%2.22B | 32.31%2.14B | 60.73%2.07B | 53.14%1.88B | 54.91%1.8B |
| -Notes receivable | 3,505.86%4.6M | --1.04M | ---- | ---- | --127.66K | ---- | ---- | ---- | ---- | ---- |
| -Accounts receivable | 7.45%2.41B | 2.22%2.27B | 1.92%2.18B | 1.00%2.09B | 19.14%2.24B | 23.35%2.22B | 32.31%2.14B | 60.73%2.07B | 53.14%1.88B | 54.91%1.8B |
| Other receivables (including interest and dividends) | 40.25%158.67M | 72.79%164.88M | 30.32%145.23M | 18.76%141.24M | 19.43%113.13M | -35.29%95.42M | -9.14%111.44M | -2.73%118.92M | -18.40%94.73M | 61.13%147.46M |
| -Other receivable | 40.25%158.67M | ---- | 30.32%145.23M | ---- | 19.43%113.13M | ---- | -9.14%111.44M | ---- | -18.40%94.73M | ---- |
| Contractual assets | 16.12%457.81M | 16.28%455.88M | 8.37%427.29M | 7.60%424.48M | 18.54%394.27M | 19.94%392.06M | 42.65%394.3M | 57.83%394.5M | 70.58%332.6M | 74.58%326.88M |
| Advance payment | -23.96%13.54M | -13.19%25.57M | -8.68%26.04M | -12.84%26.05M | -22.70%17.81M | -45.65%29.46M | -1.11%28.51M | 21.70%29.89M | -7.67%23.04M | 82.20%54.2M |
| Inventories | 10.22%1.12B | 20.17%1.2B | 14.30%1.19B | -0.10%1.07B | -2.73%1.01B | -2.24%995.03M | 12.52%1.04B | 35.99%1.07B | 53.15%1.04B | 79.34%1.02B |
| Non-current assets due within one year | ---- | ---- | ---- | 3,899.46%145.66M | 5,353.66%144.33M | 8,923.34%145.21M | 29,368.28%145.03M | --3.64M | --2.65M | --1.61M |
| Other current assets | 56.00%637.62M | 7.56%385.62M | -19.08%343.27M | 5.60%344.56M | -55.42%408.74M | -36.32%358.5M | -27.76%424.19M | -60.69%326.3M | -29.49%916.8M | -15.27%562.95M |
| Total current assets | -30.04%7.61B | -1.70%7.1B | -4.84%7.07B | 44.06%9.45B | 66.38%10.87B | 8.53%7.22B | 6.13%7.43B | -14.22%6.56B | -24.38%6.54B | -23.13%6.65B |
| Non Current assets | ||||||||||
| Debt investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --137.43M | --139.29M | --142M |
| Other non-current financial assets | -17.01%234.06M | -18.60%235.86M | -8.32%233.76M | 7.83%283.7M | 17.98%282.03M | 11.14%289.77M | 2.68%254.98M | 0.01%263.1M | -22.90%239.05M | -7.63%260.73M |
| Long-term equity investment | -10.23%648.98M | 27.87%856.22M | 12.82%734.24M | 15.49%737.05M | 14.76%722.95M | 1.30%669.61M | 8.94%650.79M | 10.35%638.22M | 39.19%629.97M | 75.92%660.99M |
| Fixed assets | 20.20%7.81B | ---- | 22.76%7.4B | ---- | 14.69%6.5B | ---- | 20.49%6.03B | ---- | 44.41%5.66B | ---- |
| Constru in process | -14.39%2.25B | ---- | -17.04%2B | ---- | 57.56%2.63B | ---- | 107.55%2.41B | ---- | 21.63%1.67B | ---- |
| Productive biological assets | 11.02%175M | -18.55%156.07M | -16.89%156.56M | -12.65%156.91M | -11.45%157.63M | -3.78%191.61M | -2.70%188.36M | 6.01%179.63M | 24.28%178.02M | 408.82%199.13M |
| Intangible assets | 0.25%791M | 1.89%800.92M | -2.37%786.01M | -4.99%787.46M | -1.68%789.06M | 8.72%786.04M | 11.14%805.05M | 10.74%828.79M | 15.82%802.53M | 11.27%723.01M |
| Goodwill | -0.73%2.76B | 2.81%2.84B | -0.94%2.79B | 3.36%2.78B | 3.46%2.78B | 7.83%2.76B | 10.98%2.81B | 13.69%2.69B | 28.22%2.69B | 41.30%2.56B |
| Long deferred expense | 30.36%678.5M | 47.53%675.86M | 47.08%705.14M | 4.80%503.91M | 4.85%520.47M | 26.26%458.13M | 97.89%479.42M | 132.50%480.83M | 189.26%496.38M | 92.92%362.84M |
| Deferred tax assets | 25.76%192.68M | 34.69%207.51M | 37.86%190.34M | 178.77%193.4M | 160.62%153.22M | 243.13%154.07M | 301.14%138.07M | 206.11%69.38M | 276.97%58.79M | 188.62%44.9M |
| Usufruct assets | -27.77%560.22M | -28.55%585.42M | -28.64%618.12M | -29.29%644.99M | -18.38%775.63M | 1.46%819.32M | 9.11%866.23M | 69.59%912.22M | 156.09%950.25M | 170.76%807.53M |
| Other non current assets | -25.93%215.69M | 20.67%316.61M | -2.84%314.85M | -22.67%342.29M | -33.65%291.22M | -40.68%262.37M | 8.97%324.07M | 48.77%442.66M | 123.94%438.91M | -2.96%442.28M |
| Total non current assets | 4.59%16.32B | 7.97%16.47B | 6.46%15.93B | 9.02%15.8B | 11.79%15.6B | 16.86%15.26B | 25.02%14.96B | 31.54%14.49B | 43.21%13.96B | 46.99%13.05B |
| Total assets | -9.63%23.93B | 4.87%23.57B | 2.71%23B | 19.94%25.24B | 29.20%26.48B | 14.05%22.48B | 18.05%22.39B | 12.79%21.05B | 11.44%20.49B | 12.38%19.71B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 32.56%764.97M | 20.53%644.67M | 20.49%556.13M | -19.52%534.47M | -12.93%577.07M | 33.45%534.85M | 12.84%461.54M | 60.62%664.08M | 57.14%662.77M | -1.64%400.79M |
| Transactional financial liabilities | ---- | -80.47%26.54M | -70.84%50.03M | 29.07%32.97M | ---- | 27.71%135.93M | 1,715.48%171.55M | --25.55M | --30.04M | --106.43M |
| Notes payable and accounts payable | 15.74%477.09M | 21.11%485.59M | 20.78%503.04M | -10.17%385.09M | 1.45%412.22M | -13.80%400.93M | -10.70%416.5M | 20.83%428.66M | 28.78%406.35M | 63.96%465.1M |
| -Accounts payable | 15.74%477.09M | 21.11%485.59M | 20.78%503.04M | -10.17%385.09M | 1.45%412.22M | -13.80%400.93M | -10.70%416.5M | 20.83%428.66M | 28.78%406.35M | 63.96%465.1M |
| Contract liabilities | 12.69%834.86M | 5.31%899.24M | -8.78%796.97M | 5.66%836.88M | -10.97%740.87M | 0.60%853.93M | 4.42%873.66M | 6.13%792.08M | 22.44%832.14M | 28.19%848.81M |
| Salaries payable | 6.35%711.1M | -6.91%609.74M | -0.36%586.88M | 3.37%727.83M | 7.23%668.66M | 15.63%654.97M | 20.90%588.98M | 28.82%704.07M | 17.99%623.56M | 27.53%566.44M |
| Taxs payable | -7.94%219.05M | -0.17%248.53M | 2.41%222.09M | 21.62%236.07M | 26.38%237.95M | 23.97%248.94M | 56.52%216.87M | 54.62%194.11M | 64.89%188.29M | 63.07%200.8M |
| Other payable (including interest and dividends) | 12.54%709.61M | 32.78%765.14M | -29.70%720.54M | -22.85%647.54M | -30.57%630.54M | -28.07%576.23M | 25.86%1.02B | 20.26%839.38M | 20.63%908.12M | 52.83%801.09M |
| -Dividend payable | ---- | ---- | -83.61%58.85M | ---- | ---- | ---- | 547.64%359.03M | 23.89%1.69M | 36.78%1.86M | 34.76%1.86M |
| -Other payable | 12.54%709.61M | ---- | -0.63%661.68M | ---- | -30.42%630.54M | ---- | -12.25%665.88M | ---- | 20.60%906.25M | ---- |
| Non current liabilities due within one year | 28.66%431.85M | 62.66%451.99M | 69.43%449.39M | 25.82%329.99M | 40.45%335.66M | 17.42%277.88M | 23.26%265.24M | 40.81%262.28M | 53.35%238.98M | 120.93%236.66M |
| Other current liabilities | 15.20%28.32M | -15.93%24.6M | 9.42%25.62M | 2.89%25.26M | 10.74%24.59M | 44.30%29.26M | 26.20%23.41M | 56.79%24.55M | 61.09%22.2M | --20.28M |
| Total current liabilities | 15.58%4.22B | 11.93%4.16B | -3.26%3.91B | -4.54%3.76B | -6.59%3.65B | 1.82%3.71B | 19.07%4.04B | 27.48%3.93B | 31.20%3.91B | 42.89%3.65B |
| Current liabilities | ||||||||||
| Long term loan | 1.61%4.38B | 396.25%4.33B | 419.98%4.33B | 474.88%4.39B | 503.94%4.31B | 26.03%872.58M | 42.50%832.16M | -14.48%764.01M | -25.39%713.34M | -25.81%692.34M |
| Bonds payable | ---- | ---- | -99.74%10.26M | -32.42%2.53B | 4.03%3.89B | 3.72%3.89B | 7.15%3.87B | 7.38%3.74B | 7.90%3.74B | 8.06%3.75B |
| Deferred tax liabilities | 0.63%291.87M | 2.54%263.49M | -9.32%241.51M | -0.33%266.64M | 11.12%290.04M | 33.32%256.96M | 29.76%266.33M | 36.33%267.52M | 50.61%261.01M | 66.62%192.74M |
| Long term deferred income | 4.66%409.98M | 34.01%381.53M | 34.46%384.87M | 76.26%386.49M | 157.07%391.71M | 83.43%284.71M | 80.57%286.22M | 49.62%219.27M | 1.96%152.38M | 1.74%155.22M |
| Lease liabilities | -31.42%401.31M | -33.11%412.71M | -32.97%450.54M | -35.33%466.16M | -23.05%585.2M | -1.67%617.05M | 7.02%672.15M | 72.45%720.82M | 167.47%760.51M | 176.22%627.51M |
| Other non current liabilities | ---- | ---- | ---- | -27.25%89.37M | 4.90%117.58M | 13.90%115.86M | 19.99%111.13M | 38.15%122.85M | 37.44%112.09M | -43.96%101.73M |
| Total non current liabilities | -42.82%5.48B | -10.74%5.39B | -10.37%5.41B | 39.27%8.13B | 66.96%9.58B | 9.37%6.04B | 14.35%6.04B | 11.64%5.84B | 12.29%5.74B | 8.64%5.52B |
| Total liabilities | -26.70%9.7B | -2.11%9.54B | -7.52%9.32B | 21.63%11.89B | 37.15%13.24B | 6.37%9.75B | 16.20%10.08B | 17.52%9.77B | 19.26%9.65B | 20.09%9.17B |
| Shareholders equity | ||||||||||
| Paid-in capital | -0.51%1.78B | 0.04%1.79B | 0.04%1.79B | 50.05%1.79B | 50.05%1.79B | 50.01%1.79B | 50.01%1.79B | 49.99%1.19B | 49.99%1.19B | 49.98%1.19B |
| Other equity instruments | ---- | ---- | ---- | -40.55%118.04M | 0.00%198.55M | 0.00%198.55M | 0.00%198.55M | 0.00%198.55M | 0.00%198.55M | 0.00%198.55M |
| Capital reserve funds | -4.09%5.01B | 2.67%5.19B | 3.93%5.17B | -1.19%5.26B | -0.62%5.22B | -11.11%5.06B | -11.60%4.97B | -11.70%5.32B | -12.55%5.25B | -6.29%5.69B |
| Surplus reserve funds | 32.82%814.22M | 45.47%613.04M | 45.47%613.04M | 45.47%613.04M | 45.47%613.04M | 26.70%421.42M | 26.70%421.42M | 26.70%421.42M | 26.70%421.42M | 64.28%332.62M |
| Retained profit | 23.79%6.44B | 27.12%6.27B | 30.19%5.96B | 20.76%5.44B | 25.34%5.2B | 28.90%4.93B | 32.71%4.58B | 29.67%4.5B | 28.88%4.15B | 40.16%3.83B |
| Less:Treasury stock | -10.18%416.27M | 13.91%527.94M | 3.35%478.97M | -28.72%463.45M | -30.62%463.45M | -30.62%463.45M | -4.28%463.45M | 48.79%650.2M | 121.33%668.04M | 359.95%668.04M |
| Other composite income | -60.61%-7.76M | 285.80%51.71M | -215.29%-42.34M | -2,352.69%-59.7M | -273.55%-4.83M | 83.39%-27.83M | 122.75%36.72M | 98.64%-2.43M | 98.96%-1.29M | -81.93%-167.59M |
| Shareholders equity without minority interests | 8.46%13.62B | 12.45%13.39B | 12.81%13.01B | 15.55%12.69B | 19.04%12.56B | 14.45%11.9B | 13.59%11.54B | 7.59%10.98B | 4.14%10.55B | 6.60%10.4B |
| Minority interests | -11.41%603.54M | -22.25%638.87M | -14.62%658.78M | 126.95%669.92M | 133.90%681.25M | 489.24%821.75M | 477.79%771.57M | 110.93%295.18M | 75.38%291.25M | -4.48%139.46M |
| Total shareholder equity | 7.44%14.22B | 10.21%14.03B | 11.09%13.67B | 18.47%13.36B | 22.12%13.24B | 20.73%12.73B | 19.61%12.31B | 8.99%11.27B | 5.29%10.84B | 6.43%10.54B |
| Total liabilityies and equity | -9.63%23.93B | 4.87%23.57B | 2.71%23B | 19.94%25.24B | 29.20%26.48B | 14.05%22.48B | 18.05%22.39B | 12.79%21.05B | 11.44%20.49B | 12.38%19.71B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.